摘要
目的探讨利托君治疗先兆早产的临床效果。方法整群选取2012年2月—2015年10月确诊的先兆早产患者252例,随机分成对照组(硫酸镁)和观察组(利托君)各126例,比较两组治疗效果和住院时间。结果观察组保胎成功率为97.6%,住院时间为(5.97±1.25)d,对照组保胎成功率为70.6%,住院时间为(13.24±3.57)d,两组相比差异具有统计学意义(P<0.05)。结论利托君治疗先兆早产的临床效果满意,值得在临床上推广应用。
Objective To investigate the clinical effect of ritodrine in the treatment of threatened premature labor. Methods Group selection a total of 252 cases of February 2012 to 2015 October diagnosed patients with threatened preterm labor,were randomly divided into control group（magnesium sulfate） and observation group（ritodrine） of 126 cases, compared two groups of treatment and hospitalization time. Results The success rate was 97.6%, hospital stay（5.97 1.25 ＋ D）, control group spuc success rate was 70.6%, the length of time for（13.24 ＋ 3.57） days, the two groups had significant difference（P〈0.05） compared group spuc observation. Conclusion The clinical effect of ritodrine in the treatment of threatened premature labor satisfaction, it is worthy of clinical application.
出处
《中外医疗》
2016年第22期122-123,共2页
China & Foreign Medical Treatment
关键词
利托君
硫酸镁
先兆早产
Ritodrine
Magnesium sulphate
Threatened premature labor
